Regenerative therapy
Does Therapeutic Plasma Exchange work?
TPE, plasma dilution
Investigational — credible
The best plasma-based evidence to date — but tiny, short, and conflicted.
What it is
An FDA-cleared apheresis procedure that removes plasma and replaces it with albumin/saline. The longevity thesis: diluting old plasma removes pro-aging factors.
The evidence
A 2025 Buck Institute / Circulate trial (single-blind, ~42 adults 50+) reported up to ~2.6 years reduction in biological-age markers with TPE+IVIG.
The honest reality
All human data are surrogate markers (epigenetic clocks/proteome) — not lifespan or disease outcomes. Samples are tiny, single-blind, unreplicated, and several authors are commercializing TPE. Clinics sell it at $1,200–$10,000/session ahead of the evidence. Not the same as debunked young-plasma infusions.
Regulatory status
FDA-cleared for specific autoimmune/neurologic conditions — NOT for aging (off-label). UAE/DHA: performed only in licensed facilities.
Frequently asked questions
Does Therapeutic Plasma Exchange work for anti-aging?
The best plasma-based evidence to date — but tiny, short, and conflicted. A 2025 Buck Institute / Circulate trial (single-blind, ~42 adults 50+) reported up to ~2.6 years reduction in biological-age markers with TPE+IVIG.
Is Therapeutic Plasma Exchange FDA-approved or safe?
FDA-cleared for specific autoimmune/neurologic conditions — NOT for aging (off-label). UAE/DHA: performed only in licensed facilities. All human data are surrogate markers (epigenetic clocks/proteome) — not lifespan or disease outcomes. Samples are tiny, single-blind, unreplicated, and several authors are commercializing TPE. Clinics sell it at $1,200–$10,000/session ahead of the evidence. Not the same as debunked young-plasma infusions.
Should I try Therapeutic Plasma Exchange?
Jevity grades Therapeutic Plasma Exchange as "Investigational — credible". All human data are surrogate markers (epigenetic clocks/proteome) — not lifespan or disease outcomes. Samples are tiny, single-blind, unreplicated, and several authors are commercializing TPE. Clinics sell it at $1,200–$10,000/session ahead of the evidence. Not the same as debunked young-plasma infusions. Any decision belongs with a licensed clinician — this is educational information, not medical advice.
Sources
Educational information only — not medical advice, a diagnosis, or a recommendation to use any substance or therapy. Regulatory status changes; verify current rules and any personal decision with a licensed clinician. Jevity is operated by Upcapital Global FZCO, Dubai, UAE.